1. Home
  2. CSBR vs IDE Comparison

CSBR vs IDE Comparison

Compare CSBR & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • IDE
  • Stock Information
  • Founded
  • CSBR 1985
  • IDE 2010
  • Country
  • CSBR United States
  • IDE United States
  • Employees
  • CSBR N/A
  • IDE N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • IDE Finance/Investors Services
  • Sector
  • CSBR Health Care
  • IDE Finance
  • Exchange
  • CSBR Nasdaq
  • IDE Nasdaq
  • Market Cap
  • CSBR 111.4M
  • IDE 173.1M
  • IPO Year
  • CSBR 1986
  • IDE N/A
  • Fundamental
  • Price
  • CSBR $7.77
  • IDE $11.69
  • Analyst Decision
  • CSBR Strong Buy
  • IDE
  • Analyst Count
  • CSBR 1
  • IDE 0
  • Target Price
  • CSBR $12.00
  • IDE N/A
  • AVG Volume (30 Days)
  • CSBR 37.5K
  • IDE 33.5K
  • Earning Date
  • CSBR 07-17-2025
  • IDE 01-01-0001
  • Dividend Yield
  • CSBR N/A
  • IDE 8.83%
  • EPS Growth
  • CSBR N/A
  • IDE N/A
  • EPS
  • CSBR 0.46
  • IDE N/A
  • Revenue
  • CSBR $58,591,000.00
  • IDE N/A
  • Revenue This Year
  • CSBR $15.11
  • IDE N/A
  • Revenue Next Year
  • CSBR $7.80
  • IDE N/A
  • P/E Ratio
  • CSBR $16.76
  • IDE N/A
  • Revenue Growth
  • CSBR 19.03
  • IDE N/A
  • 52 Week Low
  • CSBR $3.60
  • IDE $8.61
  • 52 Week High
  • CSBR $11.99
  • IDE $10.46
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 56.32
  • IDE 71.35
  • Support Level
  • CSBR $7.16
  • IDE $11.61
  • Resistance Level
  • CSBR $7.88
  • IDE $11.48
  • Average True Range (ATR)
  • CSBR 0.76
  • IDE 0.08
  • MACD
  • CSBR -0.02
  • IDE 0.00
  • Stochastic Oscillator
  • CSBR 64.47
  • IDE 88.64

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: